Catalio Capital Management, LP
CIK 0001958125 · NEW YORK, NY · Quarter end: 2025-12-31 · Filed on: 2026-09-02 · Open the SEC source ↗
The most recent 13F EDGAR holds under this CIK is 2025 Q4, filed 2026-09-02. Nothing has been filed since — the fund stopped filing, or it files under a different entity now. The positions below are a snapshot of that date, not a current portfolio.
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$565.8M
2025 Q4
Positions
45
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
51.2%
Est. Net Flow (Q)
—
2025 Q4
Top Holdings
GILD
GILEAD SCIENCES INC
6.3%
BMY
BRISTOL-MYERS SQUIBB CO
6.2%
BSX
BOSTON SCIENTIFIC CORP
6.1%
BBIO
BRIDGEBIO PHARMA INC
5.6%
LLY
ELI LILLY & CO
4.9%
DNTH
DIANTHUS THERAPEUTICS INC
4.8%
04351P101
ASCENDIS PHARMA A/S
4.5%
SNDX
SYNDAX PHARMACEUTICALS INC
4.4%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.